Quantum Surgical, an innovative surgical robotic company, is pleased to announce the creation of its Scientific Advisory Board, who met for the first time on April 8 in Amsterdam.
This Scientific Advisory Board (SAB) is a multi-disciplinary board composed of international experts in the field of image-guided interventional oncology:
- Prof. Guy Vallancien (FR), Urology surgeon, recognized as an international pioneer in the development of laparoscopic and robotic surgery, member of the French National Academy of Medicine, the Parliamentary Office for the Evaluation of Scientific and Technological Choices and founder of the European School of Surgery;
- Prof. Luigi Solbiati (IT), Interventional radiologist, pioneer of percutaneous liver ablation techniques, former head of the oncological interventional radiology department at Busto Arsizio Hospital (Varese, Lombardy);
- Prof. David C. Madoff (US), Interventional Radiologist, Head of Academic Affairs at New York Presbyterian / Weill Cornell Hospital, former Chief of Interventional Radiology;
- Prof. Boris Guiu (FR), Interventional Radiologist, Head of the Department of Diagnostic and Interventional Radiology at Saint Eloi – CHU of Montpellier and Professor at the Faculty of Medicine of Montpellier-Nîmes;
The Quantum Surgical team will be able to consult these experts and benefit from their advice in the development and clinical launch of its product.
“We are highly honored to have these outstanding experts on our Scientific Advisory Board, and to be able to put to good use all their valuable advice and clinical experience. This Scientific Advisory Board is vital in order to strengthen our strategy and development.” said Bertin Nahum, President and Founder of Quantum Surgical.
About Quantum Surgical:
Co-founded in 2017 by Bertin Nahum, Quantum Surgical is an innovative surgical robotic company based in Montpellier (France). Quantum Surgical’s robotic solution is a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer. This platform combining robotics, image analytics, and artificial intelligence will allow more and more patients to benefit from safer interventional oncology procedures, especially in the case of early-stage liver cancers. The incidence of liver cancer in the population is, unfortunately, growing very rapidly. Liver cancer is one of the most common cancers with more than 800 000 cases each year in the world.
More information is available on our website: https://quantumsurgical.com
